Science Advances · 2020 · 124 citations · 28 references
MedicineImmunologyOncologyDrug DeliveryImmunotherapyTumor MicroenvironmentCancer ImmunotherapyCancer NanomedicineCheckpoint Inhibitor TherapyCombination ImmunotherapyImmune Checkpoint InhibitorsTumor Immune MicroenvironmentBoostingCancer NanotherapyGene Delivery NanoparticlesImmune Checkpoint Inhibitor TherapyNanoparticle-based ChemotherapyTumor Microenvironment ResponsivenessTumor Microenvironment-responsive TargetingTumor-targeted Drug Delivery
Immune checkpoint blockade therapy (ICT) has shown potential in the treatment of multiple tumors, but suffers poor response rate in clinic. We found that even combining ICT with chemotherapy, which was wildly used in clinical trials, failed to achieve satisfactory tumor inhibition in the B16F10 model. Thus, we further constructed a previously unexplored immune cocktail therapy and realized multiple boosting of the cancer-immunity cycle. Cocktail therapy consisted of two kinds of tumor microenvironment-responsive drug and gene delivery nanoparticles to achieve specific delivery of doxorubicin and codelivery of plasmids expressed small hairpin RNA of PD-L1 (pshPD-L1) and hyaluronidase (pSpam1) in the tumor area. Experimental evidences proved that any component in the cocktail therapy was indispensable, and the cocktail therapy exhibited excellent antitumor effects against different types of tumors. The cocktail therapy presented here offers a searching strategy for more synergistic units with ICT and is meaningful for developing more efficient antitumor immunotherapy.
28
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang et al. · New England Journal of Medicine · 2015 · 9.4K citations · Full text
Life Sciences, Immunology, Oncology +17
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A. Jacobetz, Derek Chan, Tashinga E. Bapiro et al. · Gut · 2012 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
Christina Pfirschke, Camilla Engblom, Steffen Rickelt et al. · Immunity · 2016 · 950 citations · Full text
Medicine, Immunology, Oncology +14